Researchers from the University at Albany and NYU Grossman School of Medicine have found a way to block a key cellular ...

Researchers from the University at Albany and NYU Grossman School of Medicine have found a way to block a key cellular ...

Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 ...

Semaglutide, the active ingredient in Ozempic, and other drugs in the same class have revolutionized the treatment of obesity and type 2 diabetes. Now, a clinical trial suggests the medicines can ...

An unusual way to deliver drugs gives new meaning to the term “Jell-O shot.” Injected into rats, a water-based gel mixed with the key ingredients in Ozempic or Mounjaro offered long-lasting diabetes ...

These findings position henagliflozin at the intersection of diabetes care and longevity science. They are raising both optimism and debate over whether existing medications might also serve as ...

Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in cancer prevention. Now, a study ...

Nearly 17 million young Americans could be eligible for GLP-1RAs—a class of medications used to treat type 2 diabetes and obesity—including Ozempic and Wegovy. This is based on estimations from Yale ...

GLP-1 receptor agonists (GLP-1 RAs), medications that help control type 2 diabetes and obesity, can have a profound impact on physical wellness – but what about mental health? Some examples of these ...

U.S. sales of Lilly’s weight-loss treatment Zepbound nearly tripled, to $3.57 billion, in the third quarter. Meanwhile, ...

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with type 1 diabetes. Semaglutide, the active ingredient in Ozempic, and other ...